• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Bone loss in osteoporosis and rheumatoid arthritis diseases: The effects of disease mechanisms, age, gender and ethnic origin on responsiveness to treatment. 
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Bone loss in osteoporosis and rheumatoid arthritis diseases: The effects of disease mechanisms, age, gender and ethnic origin on responsiveness to treatment.
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Bone loss in osteoporosis and rheumatoid arthritis diseases: The effects of disease mechanisms, age, gender and ethnic origin on responsiveness to treatment.
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Bone loss in osteoporosis and rheumatoid arthritis diseases: The effects of disease mechanisms, age, gender and ethnic origin on responsiveness to treatment.

    View/Open
    Albogami_Mohammed_PhD_080515.pdf (4.283Mb)
    Publisher
    Queen Mary University of London
    Metadata
    Show full item record
    Abstract
    Bone makes up a framework that provides protection for internal body organs. The homeostasis of bone is maintained by a balanced process involving old bone degradation and new bone formation. However, this balance can be altered in pathophysiological conditions such as in postmenopausal osteoporosis and in patients with rheumatoid arthritis (RA). In recent years, new therapies have been developed to reduce bone resorption. However, there is disparity in patients’ response to these therapies. The reasons are unclear although age, gender, ethnic background and lifestyle have all been suggested to play a part. For patients with chronic inflammatory conditions, treatment was revolutionised by the discovery and application of biologic therapies that target pro-inflammatory proteins and/or pathways. However, whilst the anti-inflammatory effect of these biologic agents is well-established, their effect on bone loss is just emerging. In RA, it is not clear whether the beneficial anti-inflammatory effects of biologic anti-tumour necrosis factor alpha (TNFα) agents are accompanied by parallel improvements in bone erosion/density, whether there are differences between patient groups and what factors influence the response. In order to address these issues, a database on the factors that influence responsiveness of patients with osteoporosis to bisphosphonates, a treatment that suppresses bone resorption, was established. Based on the outcome of this study, the influence of the key factor(s) that affect bone response to treatment in combination with excess pro-inflammatory cytokine production on bone response in RA patients was determined. Significant improvement in bone mineral density (BMD) and plasma levels of bone biomarkers has been shown in this study with biologic anti-TNFα agents. The improvement in BMD was not always consistent with improvement the clinical response to treatment as assessed by changes in disease activity score 28(DAS28). The study also provides a mechanistic explanation for how blockade of TNFα in patients can reverse the balance of bone loss in patients with RA. Thus, the data show that treatment of patients with biologic anti-TNFα agents reduces the number of osteoclast precursors (OCs) in the blood.
    Authors
    Albogami, Mohammed Mater
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/8901
    Collections
    • Theses [3303]
    Copyright statements
    The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.